The role of orexin/hypocretin in regulating the sleep: Wake cycle

The neurons of the lateral hypothalamus that synthesize peptides hypocretin/orexin from a common precursor pre-pro-orexin/preprohypocretin are the key stabilizers of sleep-wake cycle. Regulation of sleep-wake cycle is achieved through a functional interaction between orexinergic neurons of the hypothalamus, monoaminergic/cholinergic neurons of the brainstem and GABAergic/galanin neurons of the ventrolateral preoptic nucleus. Orexins/hypocretins originating from the hypothalamus excite monoaminergic neurons. In contrast to this, excited monoaminergic neurons reciprocally inhibit orexinergic neurons. GABAergic neurons, which also include galanin, send inhibitory signals to monoaminergic and orexinergic neurons, while monoaminergic neurons send inhibitory signals to GABAergic neurons who are active during sleep. Such an organization, with mutual influences is of great importance for the stabilization of sleep-wake cycle. Studies have also shown that the loss of orexinergic neurons is directly related to narcolepsy, a form of hypersomnia which is characterized by the sudden intrusion of NREM and REM sleep phase to wakefulness and frequent transitions between state of sleep and wakefulness. Narcolepsy may be accompanied by cataplexy, which is manifested by the sudden weak-ness of muscle tone. Discovery of the connection between the loss of orexinergic signaling and human narcolepsy-cata-plexy has led to new diagnostic and therapeutic options in the treatment of this disease.

[1]  K. Sakimura,et al.  GABAergic neurons in the preoptic area send direct inhibitory projections to orexin neurons , 2013, Front. Neural Circuits.

[2]  M. Palkovits,et al.  Interactions between orexin–immunoreactive fibers and adrenaline or noradrenaline-expressing neurons of the lower brainstem in rats and mice , 2010, Peptides.

[3]  Takeshi Sakurai,et al.  The orexin system: roles in sleep/wake regulation , 2010, Annals of the New York Academy of Sciences.

[4]  T. Sakurai,et al.  Selective loss of GABAB receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture , 2009, Proceedings of the National Academy of Sciences.

[5]  E. Mignot,et al.  The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions. , 2006, Trends in pharmacological sciences.

[6]  K. Saitoh,et al.  Orexinergic projections to the cat midbrain mediate alternation of emotional behavioural states from locomotion to cataplexy , 2005, The Journal of physiology.

[7]  Y. Inoue,et al.  CSF hypocretin‐1 (orexin‐A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia , 2002, Journal of sleep research.

[8]  E. Mignot,et al.  Fluctuation of extracellular hypocretin‐1 (orexin A) levels in the rat in relation to the light–dark cycle and sleep–wake activities , 2001, European Journal of Neuroscience.

[9]  E. Mignot,et al.  Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy , 2001, Annals of neurology.

[10]  M. I. Smith,et al.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Sakurai,et al.  Structure and Function of Human Prepro-orexin Gene* , 1999, The Journal of Biological Chemistry.

[12]  F E Bloom,et al.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.